510(k) Report

510(k) · Cleared

Cleared

Cannabinoid Enzyme Immunoassay, Catalog 0070, 0071

K021887510(k) TraditionalCleared Aug 15, 200269-day reviewClass II21 CFR 862.3870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Lin-Zhi International, Inc. · LDJ Enzyme Immunoassay, Cannabinoids

Cleared on Aug 15, 2002 as substantially equivalent to K943998 (Diagnostic Reagents, Inc., 1994) after a 69-day review. Its family tree reaches back 1 generation to 1994. 5 later devices descend from it.

Decided
Aug 15, 2002
Review
69 days
Class
Class II
Product code
LDJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K943998 (1994). 5 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2011: 1 descendant cleared2015: 2 descendants cleared2023: 1 descendant cleared2026: 1 descendant clearedK943998 · Cannabinoid Eia Assay · Diagnostic Reagents, Inc. · 19941990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 2 descendants3 generations forward: 1 descendant4 generations forward: 1 descendant K943998 · Cannabinoid Eia Assay · Diagnostic Reagents, Inc. · 19940
  1. Root · 1 generation backK943998 Cannabinoid Eia AssayDiagnostic Reagents, Inc. · 1994
  2. This deviceK021887 Cannabinoid Enzyme Immunoassay, Catalog 0070, 0071Lin-Zhi International, Inc. · 2002
  3. Descendant · cites it directly · 4 of its ownK110239 Lzi Cannabinoids (CTHC) Homogeneous Enzyme Immunoassay, Calibrators…Lin-Zhi International, Inc. · 2011
  4. Descendant · 2 generations on · 2 of its ownK141320 LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid…Lin-Zhi International, Inc. · 2015
  5. Descendant · 3 generations on · 1 of its ownK223162 Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid…Healgen Scientific,, LLC · 2023
  6. Descendant · 4 generations on · 0 of its ownK252523 Healgen® Accurate Oral Fluid Drug Test COT/THC; Healgen® Accurate…Healgen Scientific,, LLC · 2026
  7. Descendant · 2 generations on · 0 of its ownK151203 Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC…Immunalysis Corporation · 2015

Most influential descendants

Showing 5 of 5 · See all
  • K110239Lzi Cannabinoids (CTHC) Homogeneous Enzyme Immunoassay, Calibrators, ControlLin-Zhi International, Inc. · 2011 · cites it directly4descendants
  • K141320LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators…Lin-Zhi International, Inc. · 2015 · 2 generations on2descendants
  • K223162Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test COTHealgen Scientific,, LLC · 2023 · 3 generations on1descendant
  • K252523Healgen® Accurate Oral Fluid Drug Test COT/THC; Healgen® Accurate Oral Fluid Drug TestHealgen Scientific,, LLC · 2026 · 4 generations on0descendants
  • K151203Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine Calibrators…Immunalysis Corporation · 2015 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K943998Cannabinoid Eia AssayDiagnostic Reagents, Inc.1994—
0 (this device)K021887Cannabinoid Enzyme Immunoassay, Catalog 0070, 0071Lin-Zhi International, Inc.2002—
+1K110239Lzi Cannabinoids (CTHC) Homogeneous Enzyme Immunoassay, Calibrators, ControlLin-Zhi International, Inc.2011—
+2K141320LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids…Lin-Zhi International, Inc.2015—
+3K223162Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test…Healgen Scientific,, LLC2023—
+4K252523Healgen® Accurate Oral Fluid Drug Test COT/THC; Healgen® Accurate Oral Fluid…Healgen Scientific,, LLC2026—
+2K151203Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine…Immunalysis Corporation2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
201520
202310
202610
FIG. 1 — Lineage of K021887, 1994–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LDJ device

  1. #1 K232732 Rapid Marijuana (THC) Test Strip 20, Rapid…score 9.4 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K943998Cannabinoid Eia Assay
Summary page 1
…s Cannabinoid Enzyme Immunoassay is substantially equivalent to the Cannabinoid (THC) Enzyme Immunoassay (By DRI/Microgenics Corp.), cleared under premarket notification K943998. LZI’s Cannabinoid Enzyme Immunoassay is identical or similar to its predicate in terms of intended use, method principle, devic…
Diagnostic Reagents, Inc.1994—

Also cleared against K943998: 1 other device →

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K110239Lzi Cannabinoids (CTHC) Homogeneous Enzyme Immunoassay, Calibrators, ControlLin-Zhi International, Inc.20114

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K110239 (Lin-Zhi International, Inc., 2011) has gone furthest, with 4 descendants of its own.
  • 1 other device also cites its predicate K943998.

How does its category compare?

All LDJ devices

LDJ Enzyme Immunoassay, Cannabinoids: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LDJ

2in 2024

2008: 22009: 12011: 42012: 42013: 32014: 22015: 32016: 12019: 12023: 12024: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LDJ

48in 2015

2011: 219 days median2012: 193 days median2013: 162 days median2015: 48 days median
2007high 219 (2011) · low 48 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LDJ

1in 2023

2008: 42023: 1
2007high 4 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LDJ

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code LDJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—40
20091—00
20100—00
2011421900
2012419300
2013316200
20142—00
201534801
20161—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—10
20242—00
20250—00
20260—0—

What is it indicated for?

The Cannabinoid Enzyme Immunoassay is a homogeneous enzyme immunoassay with a 20 ng/mL, 50 ng/mL (SHAHSA recommended initial test cutoff concentration), or 100 ng/mL cutoff. The assay is intended for use in the qualitative and semi-quantitative analyses of cannabinoids (THC) in human urine. The assay is designed for professional use with a number of automated clinical chemistry analyzers. The Cannabinoid Enzyme Immunoassay provides only a preliminary…

Read the full statement (109 words)

The Cannabinoid Enzyme Immunoassay is a homogeneous enzyme immunoassay with a 20 ng/mL, 50 ng/mL (SHAHSA recommended initial test cutoff concentration), or 100 ng/mL cutoff. The assay is intended for use in the qualitative and semi-quantitative analyses of cannabinoids (THC) in human urine. The assay is designed for professional use with a number of automated clinical chemistry analyzers.

The Cannabinoid Enzyme Immunoassay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GCMS) is the preferred confirmatory method. Clinical consideration and professional judgement should be -of-abuse test result, particularly when preliminary positive results are

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K021887: Cannabinoid Enzyme Immunoassay, Catalog 0070, 0071.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K021887

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026